Search Results - Dominic Pilon

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Response to the Letter to the Editor: Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA by Timothy Fitzgerald, Maryia Zhdanava, Dominic Pilon, Aditi Shah, Patrick Lefebvre, Steven R. Feldman

    Published in Dermatology and Therapy (2023-09-01)
    Get full text
    Article


  2. 2

    Treatment Patterns, Acute Healthcare Resource Use, and Costs of Patients with Treatment-Resistant Depression Completing Induction Phase of Esketamine in the United States by Lisa Harding, Kruti Joshi, Maryia Zhdanava, Aditi Shah, Arthur Voegel, Cindy Chen, Dominic Pilon

    Published in Drugs - Real World Outcomes (2024-05-01)
    Get full text
    Article


  3. 3

    Prostate-Specific Antigen Reduction After Androgen Receptor Pathway Inhibitor Initiation: Real-World Comparison of Disease Progression Among Patients With Metastatic Castration-Sen... by Shawn Du, Carmine Rossi, Ibrahim Khilfeh, Porpong Boonmak, Gordon Wong, Dominic Pilon, Lorie Ellis

    Get full text
    Article


  4. 4

    A Cross-Sectional Study of Patient Out-of-Pocket Costs for Antipsychotics Among Medicaid Beneficiaries with Schizophrenia by Dee Lin, Dominic Pilon, Laura Morrison, Aditi Shah, Marie-Hélène Lafeuille, Patrick Lefebvre, Carmela Benson

    Published in Drugs - Real World Outcomes (2023-06-01)
    Get full text
    Article


  5. 5

    Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA by Timothy Fitzgerald, Maryia Zhdanava, Dominic Pilon, Aditi Shah, Annalise Hilts, Patrick Lefebvre, Steven R. Feldman

    Published in Dermatology and Therapy (2023-03-01)
    Get full text
    Article


  6. 6

    Mental Health-Related Disability Days and Costs Among Patients with Treatment-Resistant Depression Initiated on Esketamine Nasal Spray and Conventional Therapies in the USA by Manish K. Jha, Maryia Zhdanava, Aditi Shah, Arthur Voegel, Anabelle Tardif-Samson, Dominic Pilon, Kruti Joshi

    Published in Drugs - Real World Outcomes (2025-01-01)
    Get full text
    Article


  7. 7

    Real-World Clinical Outcomes and Treatment Patterns Among Black and Non-Black Patients With Prostate Cancer Initiated on Apalutamide in a Urology Setting by Benjamin H. Lowentritt, Carmine Rossi, Erik Muser, Frederic Kinkead, Bronwyn Moore, Patrick Lefebvre, Dominic Pilon, Shawn Du

    Get full text
    Article


  8. 8

    Description of Baseline Characteristics of Pediatric Allergic Asthma Patients Including those Initiated on Omalizumab by Abhishek Kavati, Dominic Pilon, Benjamin Ortiz, Brandee Paknis, Ashok Vegesna, Bradd Schiffman, Maryia Zhdanava, Patrick Lefebvre, Brian Stone

    Published in Allergy & Rhinology (2018-04-01)
    Get full text
    Article


  9. 9

    Comparative analysis of persistence and remission with guselkumab versus secukinumab and ixekizumab in the United States by Maryia Zhdanava, Timothy Fitzgerald, Dominic Pilon, Rachel E. Teneralli, Aditi Shah, Lilian Diaz, Patrick Lefebvre, Steven R. Feldman

    Published in Journal of Dermatological Treatment (2024-12-01)
    Get full text
    Article


  10. 10

    Profiles of Medicaid Beneficiaries with Treatment-Resistant Depression Initiated on Esketamine Nasal Spray by Kristin Clemens, Maryia Zhdanava, Amanda Teeple, Arthur Voegel, Aditi Shah, Hannah E. Bowrey, Anabelle Tardif-Samson, Dominic Pilon, Kruti Joshi

    Published in Neurology and Therapy (2025-08-01)
    Get full text
    Article


  11. 11

    Time and cost burden associated with docetaxel in patients with metastatic castration-sensitive prostate cancer initiating an androgen receptor pathway inhibitor-based regimen by Daniel Sentana-Lledo, Arjun Gupta, Carmine Rossi, Sabree Burbage, Jill Korsiak, Lilian Diaz, Gordon Wong, Dominic Pilon, Ibrahim Khilfeh, Alicia K. Morgans

    Published in Frontiers in Oncology (2025-09-01)
    Get full text
    Article


  12. 12

    Overall survival in patients with metastatic castration-sensitive prostate cancer treated with apalutamide versus abiraterone acetate: a head-to-head analysis of real-world patient... by Benjamin Lowentritt, Mehmet A Bilen, Ibrahim Khilfeh, Carmine Rossi, Shawn Du, Frederic Kinkead, Lilian Diaz, Dominic Pilon, Lorie Ellis, Neal D Shore

    Article


  13. 13

    Quality measure and weight loss assessment in patients with type 2 diabetes mellitus treated with canagliflozin or dipeptidyl peptidase-4 inhibitors by Carol H. Wysham, Patrick Lefebvre, Dominic Pilon, Mike Ingham, Marie-Hélène Lafeuille, Bruno Emond, Rhiannon Kamstra, Wing Chow, Michael Pfeifer, Mei Sheng Duh

    Published in BMC Endocrine Disorders (2017-06-01)
    Get full text
    Article


  14. 14

    Adherence to First-Line Intravesical Bacillus Calmette-Guérin Therapy in the Context of Guideline Recommendations for US Patients With High-Risk Non-muscle Invasive Bladder Cancer by Franklin D. Gaylis, Bruno Emond, Ameur M. Manceur, Anabelle Tardif-Samson, Laura Morrison, Dominic Pilon, Patrick Lefebvre, Lorie A. Ellis, Hiremagalur Balaji, Andrea Ireland

    Get full text
    Article


  15. 15

    Comparison of Real-World On-Label Treatment Persistence in Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Tumor Necrosis Factor Inhibitors by Jessica A. Walsh, Iris Lin, Ruizhi Zhao, Natalie J. Shiff, Laura Morrison, Bruno Emond, Louise H. Yu, Samuel Schwartzbein, Patrick Lefebvre, Dominic Pilon, Soumya D. Chakravarty, Philip Mease

    Published in Drugs - Real World Outcomes (2024-07-01)
    Get full text
    Article


Search Tools: